Important Safety Information

RETIN-A MICRO^® (tretinoin gel) microsphere, 0.04% and 0.1% are indicated for topical application in the treatment of acne vulgaris.
RETIN-A MICRO^® 0.04% and 0.1% showed a visible reduction in total mean lesion count in as little as 2 weeks with full benefit of therapy seen after 7 weeks. The most common adverse reactions to RETIN-A MICRO^® 0.04% and 0.1% were limited to mild or moderate irritation of the skin. 1.3% of patients using RETIN-A MICRO^® 0.04% and 6% of patients using RETIN-A MICRO^® 0.1% discontinued due to irritation.

Information in this website is not intended as medical advice. Talk to your healthcare professional about medical concerns.